SynthesisFrontiers in pharmacology2024

Assessing the benefits and safety profile of incorporating poly ADP-ribose polymerase (PARP) inhibitors in the treatment of advanced lung cancer: a thorough systematic review and meta-analysis.

Min Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.